featured-image

, /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: ) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €850,000,000 principal amount of 3.650% senior notes due 2029, €850,000,000 principal amount of 3.

875% senior notes due 2036, €600,000,000 principal amount of 4.150% senior notes due 2043, and €700,000,000 principal amount of 4.150% senior notes due 2053 (collectively, the "Notes").



All of Medtronic, Inc.'s obligations under the Notes will be fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.

A., a wholly-owned subsidiary of the Company and the indirect parent of Medtronic, Inc., on a senior unsecured basis.

The net proceeds of the Offering are expected to be used for general corporate purposes, which may include repayment of outstanding commercial paper and other indebtedness. The Offering is expected to close on , subject to customary closing conditions. The joint book-running managers for the Offering are Citigroup Global Markets Limited, J.

P. Morgan Securities plc, Merrill Lynch International and Mizuho International plc. The Offering is being made only by means of a prospectus dated , and prospectus supplement (together, the "Prospectus").

You may get these documents for free by visiting EDGAR on the U.S. Securities and Exchange Commission website at .

Alternatively, copies of the Prospectus may be obtained by contacting Citigroup Global Markets Limited, t.

Back to Health Page